Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
solifenacin succinate, Quantity: 5 mg
Arrotex Pharmaceuticals Pty Ltd
Solifenacin succinate
Tablet, film coated
Excipient Ingredients: polyvinyl alcohol; lactose; magnesium stearate; iron oxide yellow; hyprolose; macrogol 8000; titanium dioxide; croscarmellose sodium; purified talc
Oral
30
(S4) Prescription Only Medicine
Solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.
Visual Identification: Light yellow coloured, round shaped, biconvex, film-coated tablets, engraved with 'APO' on one side and 'S 5' on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2016-01-12